Rosemary Kiernan

Dr. Rosemary Kiernan

Institut de génétique humaine, UMR 9002, CNRS, Université de Montpellier, Gene regulation laboratory, 141, rue de la Cardonille, 34396 Montpellier, France
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cell
Verified
Journal Article
Closed access
AWAlexandre Wagschal
Alexandre Wagschal
EREmilie Rousset
Emilie Rousset
PBPoornima Basavarajaiah
Poornima Basavarajaiah
XCXavier Contreras
Xavier Contreras
AHAlex Harwig
Alex Harwig
Rosemary KiernanRosemary Kiernan
Rosemary Kiernan

6 January 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
DLDaniel Latreille
Daniel Latreille
LBLisa Bluy
Lisa Bluy
MBMonsef Benkirane
Monsef Benkirane
Rosemary KiernanRosemary Kiernan
Rosemary Kiernan
The epigenome is defined as a type of information that can be transmitted independently of the DNA sequence, at the chromatin level, through post-translational modifications present on histone tails. Recent advances in the identification of histone 3 variants suggest a new model of information transmission through deposition of specific histone variants. To date, several non-centromeric histone 3 variants have been identified in mammals. Despite protein sequence similarity, specific deposition complexes have been characterized for both histone 3.1 (H3.1) and histone 3.3 (H3.3), whereas no deposition complex for histone 3.2 (H3.2) has been identified to date. Here, we identified human H3.2 partners by immunopurification of nuclear H3.2 complexes followed by mass spectrometry analysis. Further biochemical analyses highlighted two major complexes associated with H3.2, one containing chromatin associated factor-1 subunits and the other consisting of a subcomplex of mini chromosome maintenance helicases, together with Asf1. The purified complexes could associate with a DNA template in vitro.

19 May 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
GGGiuseppa Grasso
Giuseppa Grasso
THTakuma Higuchi
Takuma Higuchi
VMVictor Mac
Victor Mac
JBJérôme Barbier
Jérôme Barbier
MHMarion Helsmoortel
Marion Helsmoortel
Rosemary KiernanRosemary Kiernan
Rosemary Kiernan
MicroRNAs (miRNAs) are predicted to regulate the expression of >60% of mammalian genes and play fundamental roles in most biological processes. Deregulation of miRNA expression is a hallmark of most cancers and further investigation of mechanisms controlling miRNA biogenesis is needed. The double stranded RNA-binding protein, NF90 has been shown to act as a competitor of Microprocessor for a limited number of primary miRNAs (pri-miRNAs). Here, we show that NF90 has a more widespread effect on pri-miRNA biogenesis than previously thought. Genome-wide approaches revealed that NF90 is associated with the stem region of 38 pri-miRNAs, in a manner that is largely exclusive of Microprocessor. Following loss of NF90, 22 NF90-bound pri-miRNAs showed increased abundance of mature miRNA products. NF90-targeted pri-miRNAs are highly stable, having a lower free energy and fewer mismatches compared to all pri-miRNAs. Mutations leading to less stable structures reduced NF90 binding while increasing pri-miRNA stability led to acquisition of NF90 association, as determined by RNA electrophoretic mobility shift assay (EMSA). NF90-bound and downregulated pri-miRNAs are embedded in introns of host genes and expression of several host genes is concomitantly reduced. These data suggest that NF90 controls the processing of a subset of highly stable, intronic miRNAs.

21 May 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
KSKader Salifou
Kader Salifou
CBCallum Burnard
Callum Burnard
PBPoornima Basavarajaiah
Poornima Basavarajaiah
GGGiuseppa Grasso
Giuseppa Grasso
HMHelsmoortel Marion
Helsmoortel Marion
Rosemary KiernanRosemary Kiernan
Rosemary Kiernan
Chromatin-associated MRN protects highly transcribing genes from genomic instability.

21 March 2018 in Cell Research
Verified
Journal Article
Closed access
PDF file
JBJérôme Barbier
Jérôme Barbier
XCXin Chen
Xin Chen
GSGabriel Sanchez
Gabriel Sanchez
MCMuyan Cai
Muyan Cai
MHMarion Helsmoortel
Marion Helsmoortel
Rosemary KiernanRosemary Kiernan
Rosemary Kiernan

19 March 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
XCXavier Contreras
Xavier Contreras
KSKader Salifou
Kader Salifou
GSGabriel Sanchez
Gabriel Sanchez
MHMarion Helsmoortel
Marion Helsmoortel
EBEmmanuelle Beyne
Emmanuelle Beyne
Rosemary KiernanRosemary Kiernan
Rosemary Kiernan
Expression from the HIV-1 LTR can be repressed in a small population of cells, which contributes to the latent reservoir. The factors mediating this repression have not been clearly elucidated. We have identified a network of nuclear RNA surveillance factors that act as effectors of HIV-1 silencing. RRP6, MTR4, ZCCHC8 and ZFC3H1 physically associate with the HIV-1 TAR region and repress transcriptional output and recruitment of RNAPII to the LTR. Knock-down of these factors in J-Lat cells increased the number of GFP-positive cells, with a concomitant increase in histone marks associated with transcriptional activation. Loss of these factors increased HIV-1 expression from infected PBMCs and led to reactivation of HIV-1 from latently infected PBMCs. These findings identify a network of novel transcriptional repressors that control HIV-1 expression and which could open new avenues for therapeutic intervention. Following integration into the host genome, HIV-1 expression is silenced in a small population of cells, largely via epigenetic mechanisms that repress LTR-mediated transcription. This repression creates a reservoir of cells that prevent an effective cure. It is unclear how and why integrated HIV-1 becomes transcriptionally silenced. Here, we identify a network of nuclear RNA surveillance factors that repress HIV transcription and whose loss increases virus expression in latently infected J-Lat and PBMCs. These findings advance the understanding of transcriptional repression of HIV-1.